| Year |
|---|
| Current Assets |
| Cash & Short Term Investments |
| Cash And Cash Equivalents |
| Short Term Investments |
| Net Receivables |
| Inventory |
| Other Current Assets |
| Non-Current Assets |
| Property, Plant & Equipment |
| Goodwill And Intangible Assets |
| Goodwill |
| Intangible Assets |
| Long Term Investments |
| Tax Assets |
| Other Non-Current Assets |
| Other Assets |
| Total Assets |
| Current Liabilities |
| Accounts Payable |
| Short Term Debt |
| Tax Payables |
| Deferred Revenue |
| Other Current Liabilities |
| Total Current Liabilities |
| Total Non-Current Liabilities |
| Long-Term Debt |
| Deferred Revenue |
| Deferred Taxes Liabilities |
| Other Non Current liabilities |
| Total Liabilities |
| Other Liabilities |
| Stockholders Equity |
| Common Stock |
| Retained Earnings |
| Accumulated Other Comprehensive Income/Loss |
| Other Shareholders Equity |
| Total Liabilities and Stockholders Equity |
Pfizer Limited
PFIZER.NS
NSE
4080.25INR45.35 (1.12%)
PFIZER.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 14.6B | 11.33B |
| Net Income | 5.51B | 6.24B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -1.83B | -2.97B |
| Retained Earnings | 18.28B | 14.6B |
| Other Distributions | 1.85B | 293.7M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 1.52B | 1.85B |
| Annual Depreciation | 622.8M | 1.04B |
| Capital Expenditure | -189.3M | -649.8M |
| Net PPE | 1.08B | 1.46B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 5.27B | 5.27B |
| Goodwill | 5.27B | 5.27B |